Moderna CEO Stéphane Bancel said on Tuesday he expects to be able to submit clinical data from COVID-19 vaccine trials on six to 11-year-olds to Health Canada in early fall, with data on the under six age group coming by the end of the year, or early in 2022.
COVID-19
Moderna CEO says clinical data from COVID-19 vaccine trials on 6 to 11 year-olds coming in the fall
More Videos
-
Health Matters: Rising measles cases being fueled in part by vaccine hesitancy around the world, study shows
-
Health Matters: COVID-19 vaccine may help cancer treatments, study finds
-
‘Freedom Convoy’ leaders Tamara Lich, Chris Barber sentenced 12 months house arrest, 6 months curfew
-
Health Matters: Obesity on the rise among Canadian adults
-
Quebec joins Alberta in ending free COVID-19 vaccines for some people
-
Health Matters: COVID-19 positivity rate increasing across Canada, report shows
You are viewing an Accelerated Mobile Webpage.
View Original Article